The use of Sambucus Comp. in the treatment of postnasal drip

ISRCTN	ISRCTN84244658
DOI	https://doi.org/10.1186/ISRCTN84244658
Protocol serial number	N0176127651
Sponsor	Department of Health
Funder	Oxford Radcliffe Hospitals NHS Trust (UK)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Mr Grant J E M Bates
Scientific

ENT Department
Radcliffe Infirmary
Woodstock Road
Oxford
OX2 6HE
United Kingdom

Phone	+44 (0)1865 311188
Email	abc@email.com

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title	The use of Sambucus Comp. in the treatment of postnasal drip
Study objectives	The aim of the study is to ascertain whether the anthroposophic medicine, Sambucus Comp. has a role in the treatment of postnasal drip.
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Ear, Nose and Throat
Intervention	Sambucus Comp. vs standard practice
Intervention type	Drug
Phase	Not Applicable
Drug / device / biological / vaccine name(s)	Sambucus Comp.
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	01/04/2004

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Target sample size at registration	376
Key inclusion criteria	Not provided at time of registration
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/03/2003
Date of final enrolment	01/04/2004

Radcliffe Infirmary

Oxford
OX2 6HE
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

31/03/2020: No publications found, all search options exhausted, study status unverified.